(Q44394938)

English

Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

scientific article published on 8 April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

based on heuristic

inferred from title

Hisashi Higuchi

6

object named as

Hisashi Higuchi

1 reference

Europe PubMed Central

2 December 2017

author name string

Gisa Gerstenberg

1

1 reference

Europe PubMed Central

2 December 2017

Toshiaki Aoshima

2

1 reference

Europe PubMed Central

2 December 2017

Takashi Fukasawa

3

1 reference

Europe PubMed Central

2 December 2017

Keizo Yoshida

4

1 reference

Europe PubMed Central

2 December 2017

Hitoshi Takahashi

5

1 reference

Europe PubMed Central

2 December 2017

Yoshiko Murata

7

1 reference

Europe PubMed Central

2 December 2017

Ritsuko Shimoyama

8

1 reference

Europe PubMed Central

2 December 2017

Tadashi Ohkubo

9

1 reference

Europe PubMed Central

2 December 2017

Tetsuo Shimizu

10

1 reference

Europe PubMed Central

2 December 2017

Koichi Otani

11

1 reference

Europe PubMed Central

2 December 2017

publication date

8 April 2003

1 reference

Europe PubMed Central

2 December 2017

Psychopharmacology

1 reference

Europe PubMed Central

2 December 2017

167

1 reference

Europe PubMed Central

2 December 2017

4

1 reference

Europe PubMed Central

2 December 2017

443-448

1 reference

Europe PubMed Central

2 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-003-1430-1

0 references

Relationship between plasma level and therapeutic effect of nortriptyline.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Review of the animal pharmacology and pharmacokinetics of fluvoxamine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Effects of the CYP 2D6 genotype and cigarette smoking on the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Drug metabolism in epileptics: in vivo and in vitro correlations

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1430-1

21 January 2018

Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subjective side effects of mianserin in relation to plasma concentrations of mianserin and desmethylmianserin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of imipramine plasma levels for depressive illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant activity of 2-hydroxydesipramine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desipramine plasma concentration and antidepressant response

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

17 Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine and chlorimipramine in endogenous depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine maleate: metabolism in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided daily dose regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/12682708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-003-1430-1

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44394938&oldid=2020958962"